Novan Inc (NASDAQ:NOVN) major shareholder Life Sciences Holdings L. Malin bought 800,000 shares of Novan stock in a transaction on Monday, September 26th. The stock was acquired at an average price of $11.00 per share, with a total value of $8,800,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Shares of Novan Inc (NASDAQ:NOVN) opened at 22.54 on Thursday. The firm has a 50-day moving average of $20.92 and a 200-day moving average of $20.92. Novan Inc has a 1-year low of $13.77 and a 1-year high of $23.79.

About Novan

Novan, Inc is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs).

5 Day Chart for NASDAQ:NOVN

Receive News & Stock Ratings for Novan Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novan Inc and related stocks with our FREE daily email newsletter.